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Differential effects of pharmacologic stressors:
More than meets the eye
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Pharmacologic stress for myocardial perfusion im-
aging or inducible wall motion abnormality assessment
is an established and widely accepted alternative to
physical exercise, and represents the method of choice in
many patients with limited exercise capacity. The diag-
nostic performance of such testing may by subject to a
substantial variability according to the combination of
stress agents and respective imaging modality.1 There-
fore, it is important to know the mechanism of action for
each stressor to achieve the maximal clinical benefit for
each patient. It generally is supported that pharmacologic
stress by vasodilators such as adenosine and dipyridam-
ole causes near-maximal hyperemic myocardial blood
flow (MBF) response. This allows accurate detection of
coronary artery disease (CAD) by inducing flow hetero-
geneities because flow increase in territories subtended
by stenotic coronary arteries is blunted compared with
remote segments. Only in a minority of patients and
mainly in case of high-grade stenotic lesions may aden-
osine cause steal effects and induce real ischemia as
evidenced by wall motion abnormalities.1 By contrast,
dobutamine indirectly increases MBF by increasing myo-
cardial contractility and consequently oxygen consumption,
which needs to be matched by an increase in MBF, mainly
mediated by the metabolic pathway. Again, this increase is
blunted by stenotic lesions causing flow-response dispar-
ity between stenotic and remote segments indicative of
CAD. In addition, the blunted increase to dobutamine
stimulation may induce real ischemia as a result of the
oxygen demand–supply mismatch. Because this mecha-
nism appears to better mimic the physiologic situation of
exercise-induced ischemia compared with vasodilators,
one intuitively may expect diagnostic superiority of
dobutamine and bicycle stress over vasodilator stress.
Interestingly, however, in clinical trials adenosine proved
at least equivalent to inotropic stressors.2-4
The study by Jagathesan et al5 adds to the mecha-
nistic explanation of this observation. In 36 patients with
single-vessel CAD and 18 healthy volunteers the re-
sponse to either dobutamine or adenosine stress was
assessed with positron emission tomography and 15O-
labeled water. In healthy volunteers and in remote
segments of CAD patients, adenosine achieved signifi-
cantly greater hyperemia than dobutamine. The latter
induced MBF responses comparing well with those
reported for bicycle exercise in healthy volunteers6 and
in CAD patients.7 In myocardial segments subtended by
a significant coronary stenosis, there was progressive
blunting of regional MBF with both agents. Surprisingly,
however, dobutamine achieved greater hyperemia. This
greater hyperemia with dobutamine may be owing to
more pronounced collateral recruitment whereas the
tendency of vasodilator agents to induce coronary steal
may play a modest role. Consequently, flow disparity
was greater with adenosine stress at all grades of coro-
nary stenoses. This is in agreement with a recent meta-
analysis on pharmacologic stress testing supporting the
highest sensitivity and lowest specificity to be attained
by use of vasodilator combined with myocardial perfu-
sion imaging, while the highest specificity and lowest
sensitivity to be attained by use of a vasodilator and an
inducible wall motion abnormality. The lower diagnostic
sensitivity attributed to dobutamine stress may be ex-
plained in part by less pronounced flow heterogeneities
and in part by the higher sensitivity of abnormal perfu-
sion over regional dysfunction as described by the
ischemic cascade.
In addition to providing mechanistic insights, the
results by Jagathesan et al5 are important for another
reason. In contrast to the semiquantitative information on
flow heterogeneity provided by single photon emission
computed tomography, positron emission tomography
provides absolute quantification of MBF at rest and
during pharmacologic stress, allowing calculation of
coronary flow reserve (CFR) as the ratio of stress over
resting MBF. CFR is used as an integrated measure of
flow through both the large epicardial coronary arteries
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and the microcirculation8 and has been proposed as an
indirect parameter to evaluate the function of the coro-
nary circulation. It is crucial to know the variance in CFR
induced by different agents because Jagathesan et al5
showed that CFR values obtained with vasodilators are
not interchangeable with those obtained with inotropic
stimulation. Monitoring of treatment effects by CFR
must be performed with the same stress agent to allow
meaningful interpretation of CFR.
Acknowledgment
The author has indicated he has no financial conflicts of
interest.
References
1. Paetsch I, Jahnke C, Wahl A, Gebker R, Neuss M, Fleck E, et al.
Comparison of dobutamine stress magnetic resonance, adenosine
stress magnetic resonance, and adenosine stress magnetic resonance
perfusion. Circulation 2004;110:835-42.
2. Levine MG, Ahlberg AW, Mann A, White MP, McGill CC, Mendes
de Leon C, et al. Comparison of exercise, dipyridamole, adenosine,
and dobutamine stress with the use of Tc-99m tetrofosmin tomo-
graphic imaging. J Nucl Cardiol 1999;6:389-96.
3. Wright GA, McDade M, Keeble W, Martin W, Hutton I. Quantita-
tive gated SPECT myocardial perfusion imaging with 201Tl: an
assessment of the limitations. Nucl Med Commun 2000;21:1147-51.
4. Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N,
Burnette J, et al. Prognostic value of normal exercise and adenosine
(99m)Tc-tetrofosmin SPECT imaging: results from the multicenter
registry of 4,728 patients. J Nucl Med 2003;44:134-9.
5. Jagathesan R, Barnes E, Rosen S, Foale R, Camici P. Comparison of
myocardial blood flow and coronary flow reserve during dobut-
amine and adenosine: implications for pharmacologic stress testing
in coronary artery disease. J Nucl Cardiol 2006;3:324-32.
6. Wyss CA, Koepfli P, Mikolajczyk K, Burger C, von Schulthess GK,
Kaufmann PA. Bicycle exercise stress in PET for assessment of
coronary flow reserve: repeatability and comparison with adenosine
stress. J Nucl Med 2003;44:146-54.
7. Wyss CA, Koepfli P, Fretz G, Seebauer M, Schirlo C, Kaufmann
PA. Influence of altitude exposure on coronary flow reserve.
Circulation 2003;108:1202-7.
8. Kaufmann PA, Camici PG. Myocardial blood flow measurement
by PET: technical aspects and clinical applications. J Nucl Med
2005;46:75-88.
312 Kaufmann Journal of Nuclear Cardiology
Differential effects of pharmacologic stressors May/June 2006
